#lipid-nanoparticle-technology

[ follow ]
#intellectual-property #patent-litigation #mrna-vaccines #arbutus-vs-moderna-settlement
Intellectual property law
fromAbove the Law
1 day ago

Super Settlement Spike - Above the Law

Arbutus and Moderna settled a long-running patent dispute over lipid nanoparticle technology used in mRNA vaccines, ending one of the most valuable patent assertions in history.
fromMedCity News
1 week ago

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology - MedCity News

Today represents the first real acknowledgement that team and those scientists have gotten that their technology was instrumental in Covid-19 vaccines, or at least the Moderna vaccine as we're announcing today with this settlement. This settlement validates the scientific contributions made by the researchers at Arbutus and Genevant in developing the lipid nanoparticle delivery system.
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
1 week ago

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute

The settlement resolves all U.S. and international patent litigation concerning the unauthorized use of Genevant's and Arbutus' lipid nanoparticle (LNP) delivery technology in Moderna's COVID-19 vaccines. The agreement came just days before a highly anticipated jury trial was scheduled to begin in the U.S. District Court for the District of Delaware.
Intellectual property law
[ Load more ]